Back to JNJ Stock Lookup

JNJ Related

May 21, 2013 02:05 AM Cordis Showcases Cardiovascular Innovations at EuroPCR 2013

May 15, 2013 06:19 PM Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data

May 15, 2013 04:41 PM Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)

May 15, 2013 04:15 PM SIMPONI® (golimumab) Receives FDA Approval for Ulcerative Colitis

May 13, 2013 05:16 PM Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheter

May 13, 2013 08:04 AM J&J's (JNJ) Janssen Receives Priority Review from FDA for Simeprevir

May 13, 2013 08:00 AM U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C

May 9, 2013 09:49 AM First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ™ Pulmonary Vein Isolation System™ in the Treatment of Paroxysmal Atrial Fibrillation

May 9, 2013 09:01 AM Human Performance Institute Division of Johnson & Johnson’s Wellness & Prevention, Inc. Announces New, Web-based Energy Management Program

May 8, 2013 03:32 PM Form 4 JOHNSON & JOHNSON For: May 07 Filed by: CULLEN JAMES

May 8, 2013 08:50 AM Biosense Webster Showcases Cutting Edge Innovation and Leadership in AF Ablation at HRS Annual Scientific Sessions 2013

May 7, 2013 06:00 AM Davis Names Top 25 Brand Leaders for 2012

May 6, 2013 08:30 AM FDA Grants Premarket Approval (PMA) For The SEDASYS® System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures

May 6, 2013 08:00 AM Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma

May 3, 2013 06:32 PM FDA Grants Premarket Approval (PMA) For The SEDASYS® System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures

May 3, 2013 04:04 PM Form 10-Q JOHNSON & JOHNSON For: Mar 31

May 3, 2013 11:02 AM Dow Breaks Above 15,000 for First Time

May 2, 2013 05:00 PM Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liv

May 1, 2013 03:05 PM First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting

May 1, 2013 12:07 PM Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration

May 1, 2013 08:34 AM First Manhattan Comments on Addition to Vivus’ Board of Directors

Apr 26, 2013 04:41 PM Form 8-K JOHNSON & JOHNSON For: Apr 25

Apr 25, 2013 10:38 AM Johnson & Johnson (JNJ) Raises Quarterly Dividend 8.2% to $0.66; 3.1% Yield

Apr 25, 2013 10:37 AM Johnson & Johnson Announces Dividend Increase of 8.2%

Apr 24, 2013 08:06 AM Janssen Therapeutics LINCC™ Program Continues its Commitment to Underserved Populations with Charitable Contributions to 16 HIV/AIDS Organizations Across the U.S.

Apr 23, 2013 10:04 AM Johnson & Johnson to Host Pharmaceuticals Business Review

Apr 22, 2013 06:46 AM Latest news in modern diabetes management now available online for Health Care professionals

Apr 19, 2013 08:18 AM Jefferies Trims Estimates, Ups PT on Johnson & Johnson (JNJ) Post Q1

Apr 18, 2013 10:11 AM Notable Mergers and Acquisitions of the Day 04/18: (ADK) (ROP) (JNJ)/(ELN)

Apr 18, 2013 09:53 AM J&J's (JNJ) Janssen Sells 82M Elan (ELN) ADS

Apr 18, 2013 09:50 AM Johnson & Johnson Announces Sale of Elan American Depositary Shares to Elan

Apr 18, 2013 09:25 AM BabyCenter® Reveals the Latest Profile of the 21st Century Social Mom: Her World Is Social

Apr 18, 2013 08:00 AM Richard Petty Teams Up With Janssen Biotech to Launch Show Your Stripes for Prostate Cancer Awareness

Apr 17, 2013 10:49 AM Goldman Maintains Sell on Johnson & Johnson (JNJ); Drug Business Spin Still Unlikely

Apr 16, 2013 03:16 PM Notable 52-Week Highs and Lows of the Day 04/16: (KO) (JNJ) (ECTY) High; (NTGR) (ABX) (WLT) Low

Apr 16, 2013 09:32 AM StreetInsider.com Pre-Open Movers 4/16: (ANEN) (HK) (KO) Higher; (CLI) (LDK) (SRPT) Lower (more...)

Apr 16, 2013 09:09 AM Johnson & Johnson (JNJ) Sees FY13 Revs at $70.4B - $71.1B; Est. at $71.1B

Apr 16, 2013 08:35 AM Form 8-K JOHNSON & JOHNSON For: Apr 16

Apr 16, 2013 07:47 AM Johnson & Johnson (JNJ) Tops Q1 EPS by 3c; Reaffirms FY EPS Outlook

Apr 16, 2013 07:45 AM Johnson & Johnson Reports 2013 First-Quarter Results:

Apr 15, 2013 02:46 PM Trading Radar for 04/16: Goldman (GS), Intel (INTC), Yahoo! (YHOO), J&J (JNJ), Coca-Cola (KO) Report

Apr 11, 2013 07:47 AM Johnson & Johnson to Webcast Annual Meeting of Shareholders

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Apr 9, 2013 07:17 AM Look And Feel Great This Spring, Despite Allergy Symptoms

Apr 8, 2013 10:46 AM Notable Analyst Rating Changes 04/08: (FNFG) (FLEX) (JNPR) Upgraded; (GOOG) (JNJ) (MHR) Downgraded

Apr 8, 2013 07:19 AM JPMorgan Downgrades Johnson & Johnson (JNJ) to Neutral

Apr 8, 2013 06:30 AM Ibrutinib Receives Third Oncology Breakthrough Therapy Designation from U.S. Food and Drug Administration

Apr 4, 2013 08:50 AM Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures

Apr 3, 2013 02:25 PM Next-Generation Circulating Tumor Cell Test Demonstrates High Efficiency and Accuracy in New Study

Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation

Back to JNJ Stock Lookup